Please login to the form below
Advent
This page shows the latest Advent news and features for those working in and with pharma, biotech and healthcare.
UK immunology biotech MiroBio launches with $34m fundraising
MiroBio’s Series A financing was co-led by Oxford Sciences Innovation and Samsara Biocapital, with Advent Life Sciences and SR One also joining the round. ... For the time being MiroBio has four directors – one apiece from each of its backers –
Latest news
-
Hudson named Brandicourt’s successor as Sanofi’s CEO
deal and selling off its European generics business to private equity group Advent for $2.4bn, whilst implementing a big cost-reduction programme.
-
Gottlieb admonishes industry for clinical trial failings
Gottlieb – who is leaving the FDA next month and will be replaced on an interim basis by National Cancer Institute (NCI) director Ned Sharpless – says that the advent in precision medicine,
-
Pfizer’s flat sales focus investor attention on M&A
In the last few weeks Sanofi has sold its European generics business to Advent, GlaxoSmithKline divested its rare disease unit to start-up Orchard Therapeutics after buying Novartis out of a
-
P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit
In the last few weeks Sanofi has sold its European generics business to Advent, GlaxoSmithKline divested its rare disease unit to start-up Orchard Therapeutics after buying Novartis out of a
-
Sanofi sells European generics to Advent for $2.4bn
The deal will create a new, independent European generics company. Private equity group Advent has agreed a 1.9bn ($2.4bn) deal to buy the European generics unit of French pharma ... Sanofi has been looking to divest the Zentiva generics unit since 2016
More from news
Approximately 3 fully matching, plus 94 partially matching documents found.
Latest Intelligence
-
Follow the user – democratising medical conference design
webinar. With the advent of a highly contagious virus, priorities changed and the wish to avoid infection became as strong as the need to learn about the virus’s implications for
-
Three ways AI will change healthcare in the next decade
format. The advent of natural speech means that doctors will even be able to ask the AI questions verbally and receive accurate responses as though they were seeking help from a
-
Successful product commercialisation: what can we learn from the rare disease setting?
This trend is not surprising – in part driven by the pressures facing healthcare budgets through the rising incidence of chronic diseases, as well as the advent of cell and gene therapies
-
Treatment and prevention of cardiovascular disease
These findings represented a potentially notable advance in cardiovascular disease prevention, after the advent of statins approximately thirty years ago.
-
How can virtual pharma companies de-risk new product launches?
With the advent of serialisation and traceability requirements, compliance regulations have become even more complicated and consultants who specialised in this area years ago may not now understand more recent developments
More from intelligence
Approximately 0 fully matching, plus 38 partially matching documents found.
Latest from PMHub
-
Out Of Office: The New Normal for Ad Agencies
The advent of online approval and asset management. The decline of the salesforce.
-
Digital Nation: How Australia became a digital health pioneer
With the advent of these technologies and the many benefits they bring, it is of little surprise that governments worldwide are looking to leverage new digital tools to improve the delivery
-
Spotlight interview: 15 minutes on patient engagement in pharma
Now, with the advent of technology and information being available at everyone’s fingertips, patients are becoming much more informed about different diagnoses, treatments, and which products are effective and ineffective
-
Turning learning into action: The challenge of behaviour change
Developing meaningful metrics. In addition to the use of evidence-based tools to establish the drivers of and barriers to behavioural change, the advent of digital technology and real-time data
-
'Fake news': battling misinformation in healthcare
With the advent of the internet and the popularity of new websites, the public expects information instantly.
More from PMHub
Approximately 0 fully matching, plus 17 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Senior Content Editor - Biotechnology
-
Salary TBC
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- GSK discontinues two feladilimab trials in head and neck cancer
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- FDA approves new self-injection administration for Xolair
- Lilly asks to revoke emergency authorisation for bamlanivimab monotherapy in the US
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Alexion and NICE agree confidential discount for Ultomiris use on the NHS
- Novartis’ MS therapy Kesimpta reduces risk of disability progression regardless of relapses
- Merck & Co halts development of potential COVID-19 drug MK-7110
- Virtually, the same: Is it time to rethink congress strategy?
PMHub
Bedrock Group
Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...
Latest intelligence
- InSite Events™ National Pharma Meeting: A Customer Story
- How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
- Fear or encouragement, which is best to drive behaviour change?
- The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
- The unheard, unseen, and uncorrected effects of COVID-19
- The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...
Quick links
Infographics
